Filing Details

Accession Number:
0001181431-12-047855
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-29 16:12:19
Reporting Period:
2012-08-27
Filing Date:
2012-08-29
Accepted Time:
2012-08-29 15:12:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355818 L Judy Brown C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-27 12,840 $110.66 30,363 No 4 M Direct
Common Stock Disposition 2012-08-27 5,239 $110.66 25,734 No 4 F Direct
Common Stock Acquisiton 2012-08-27 7,735 $110.66 33,469 No 4 M Direct
Common Stock Disposition 2012-08-27 3,156 $110.66 30,313 No 4 F Direct
Common Stock Disposition 2012-08-28 12,180 $110.65 18,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2012-08-27 12,840 $0.00 12,840 $0.00
Common Stock Restricted Stock Units Disposition 2012-08-27 7,735 $0.00 7,735 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-08-27 2012-08-27 No 4 M Direct
0 2012-08-27 2012-08-27 No 4 M Direct
Footnotes
  1. Vesting of Performance-based Restricted Stock Units granted on August 25, 2009.
  2. Vesting of Restricted Stock Units granted on August 25, 2009.
  3. This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on December 5, 2011. This 10b5-1 sales plan will expire on the close of business December 1, 2012.
  4. The price in column 4 is a weighted average. The prices actually received ranged from $110.15 to $111.06. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.